Top Vaccines companies in Australia by EBITDA
This ranking features the top 5 Vaccines companies in Australia ranked by EBITDA, totaling a EBITDA of USD 4.67 B, for February 06, 2025.
Australia
Vaccines
EBITDA
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 4.73 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
| 2 |
USD -4.13 M
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
| 3 |
USD -13.05 M
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
| 4 |
USD -18.50 M
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
| 5 |
USD -29.70 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
Frequently Asked Questions
-
Which Vaccines company in Australia has the highest EBITDA ?
The Vaccines company in Australia with the highest EBITDA is CSL Limited (ASX: CSL.AX) at USD 4.73 B.
-
Which Vaccines company in Australia has the lowest EBITDA ?
The Vaccines company in Australia with the lowest EBITDA is Immutep Limited (NasdaqGM: IMMP) at USD -29.70 M.
-
What are the top 10 Vaccines companies in Australia by EBITDA ?
The top 10 Vaccines companies in Australia by EBITDA are CSL Limited, Immuron Limited, Alterity Therapeutics Limited, Incannex Healthcare Limited and Immutep Limited.
-
What are the bottom 10 Vaccines companies in Australia by EBITDA ?
The bottom 10 Vaccines companies in Australia by EBITDA are Immutep Limited, Incannex Healthcare Limited, Alterity Therapeutics Limited, Immuron Limited and CSL Limited.
